vs
Side-by-side financial comparison of AbbVie (ABBV) and Smurfit Westrock (SW). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($15.0B vs $7.6B, roughly 2.0× Smurfit Westrock). AbbVie runs the higher net margin — 4.6% vs 1.3%, a 3.4% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs 0.5%). Over the past eight quarters, Smurfit Westrock's revenue compounded faster (60.8% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Smurfit Westrock plc is an Irish company based in Dublin, Ireland that manufactures corrugated and paper-based packaging. Its stock is listed on the New York Stock Exchange and the London Stock Exchange.
ABBV vs SW — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $7.6B |
| Net Profit | $697.0M | $97.0M |
| Gross Margin | — | 18.2% |
| Operating Margin | 26.6% | 5.1% |
| Net Margin | 4.6% | 1.3% |
| Revenue YoY | 9.9% | 0.5% |
| Net Profit YoY | -46.0% | -33.6% |
| EPS (diluted) | $0.39 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | — | ||
| Q4 25 | $16.6B | $7.6B | ||
| Q3 25 | $15.8B | $8.0B | ||
| Q2 25 | $15.4B | $7.9B | ||
| Q1 25 | $13.3B | $7.7B | ||
| Q4 24 | $15.1B | $7.5B | ||
| Q3 24 | $14.5B | $7.7B | ||
| Q2 24 | $14.5B | $3.0B |
| Q1 26 | $697.0M | — | ||
| Q4 25 | $1.8B | $97.0M | ||
| Q3 25 | $186.0M | $246.0M | ||
| Q2 25 | $938.0M | $-28.0M | ||
| Q1 25 | $1.3B | $384.0M | ||
| Q4 24 | $-22.0M | $146.0M | ||
| Q3 24 | $1.6B | $-150.0M | ||
| Q2 24 | $1.4B | $132.0M |
| Q1 26 | — | — | ||
| Q4 25 | 72.6% | 18.2% | ||
| Q3 25 | 66.4% | 19.6% | ||
| Q2 25 | 71.8% | 19.1% | ||
| Q1 25 | 70.0% | 20.6% | ||
| Q4 24 | 70.9% | 19.1% | ||
| Q3 24 | 70.9% | 17.6% | ||
| Q2 24 | 70.9% | 23.3% |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 27.3% | 5.1% | ||
| Q3 25 | 12.1% | 6.6% | ||
| Q2 25 | 31.7% | 3.2% | ||
| Q1 25 | 28.0% | 7.2% | ||
| Q4 24 | -9.9% | 5.3% | ||
| Q3 24 | 26.5% | 0.7% | ||
| Q2 24 | 27.6% | 8.2% |
| Q1 26 | 4.6% | — | ||
| Q4 25 | 10.9% | 1.3% | ||
| Q3 25 | 1.2% | 3.1% | ||
| Q2 25 | 6.1% | -0.4% | ||
| Q1 25 | 9.6% | 5.0% | ||
| Q4 24 | -0.1% | 1.9% | ||
| Q3 24 | 10.8% | -2.0% | ||
| Q2 24 | 9.5% | 4.4% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.02 | $0.18 | ||
| Q3 25 | $0.10 | $0.47 | ||
| Q2 25 | $0.52 | $-0.05 | ||
| Q1 25 | $0.72 | $0.73 | ||
| Q4 24 | $-0.03 | $-0.12 | ||
| Q3 24 | $0.88 | $-0.30 | ||
| Q2 24 | $0.77 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $892.0M |
| Total DebtLower is stronger | — | $13.4B |
| Stockholders' EquityBook value | — | $18.3B |
| Total Assets | — | $45.2B |
| Debt / EquityLower = less leverage | — | 0.73× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.3B | $892.0M | ||
| Q3 25 | $5.7B | $851.0M | ||
| Q2 25 | $6.5B | $778.0M | ||
| Q1 25 | $5.2B | $797.0M | ||
| Q4 24 | $5.6B | $855.0M | ||
| Q3 24 | $7.3B | — | ||
| Q2 24 | $13.2B | $26.8K |
| Q1 26 | — | — | ||
| Q4 25 | $58.9B | $13.4B | ||
| Q3 25 | $63.0B | $13.3B | ||
| Q2 25 | $63.0B | $13.3B | ||
| Q1 25 | $64.5B | $12.9B | ||
| Q4 24 | $60.3B | $12.5B | ||
| Q3 24 | $58.5B | $13.2B | ||
| Q2 24 | $58.0B | — |
| Q1 26 | — | — | ||
| Q4 25 | $-3.3B | $18.3B | ||
| Q3 25 | $-2.6B | $18.4B | ||
| Q2 25 | $-183.0M | $18.3B | ||
| Q1 25 | $1.4B | $17.9B | ||
| Q4 24 | $3.3B | $17.4B | ||
| Q3 24 | $6.0B | $18.0B | ||
| Q2 24 | $6.8B | $14.5K |
| Q1 26 | — | — | ||
| Q4 25 | $134.0B | $45.2B | ||
| Q3 25 | $133.9B | $45.6B | ||
| Q2 25 | $137.2B | $45.7B | ||
| Q1 25 | $136.2B | $44.6B | ||
| Q4 24 | $135.2B | $43.8B | ||
| Q3 24 | $143.4B | $45.0B | ||
| Q2 24 | $141.9B | $26.8K |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | 45.44× | 0.72× | ||
| Q4 24 | 18.15× | 0.72× | ||
| Q3 24 | 9.70× | 0.73× | ||
| Q2 24 | 8.56× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.2B |
| Free Cash FlowOCF − Capex | — | $612.0M |
| FCF MarginFCF / Revenue | — | 8.1% |
| Capex IntensityCapex / Revenue | — | 7.7% |
| Cash ConversionOCF / Net Profit | — | 12.32× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | $1.2B | ||
| Q3 25 | $7.0B | $1.1B | ||
| Q2 25 | $5.2B | $829.0M | ||
| Q1 25 | $1.6B | $235.0M | ||
| Q4 24 | $7.0B | $781.0M | ||
| Q3 24 | $5.4B | $320.0M | ||
| Q2 24 | $2.3B | $340.0M |
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $612.0M | ||
| Q3 25 | $6.6B | $523.0M | ||
| Q2 25 | $4.9B | $307.0M | ||
| Q1 25 | $1.4B | $-242.0M | ||
| Q4 24 | $6.8B | $212.0M | ||
| Q3 24 | $5.2B | $-192.0M | ||
| Q2 24 | $2.0B | $163.0M |
| Q1 26 | — | — | ||
| Q4 25 | 29.4% | 8.1% | ||
| Q3 25 | 42.1% | 6.5% | ||
| Q2 25 | 31.7% | 3.9% | ||
| Q1 25 | 10.5% | -3.2% | ||
| Q4 24 | 44.7% | 2.8% | ||
| Q3 24 | 35.9% | -2.5% | ||
| Q2 24 | 14.0% | 5.5% |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 7.7% | ||
| Q3 25 | 2.4% | 7.6% | ||
| Q2 25 | 1.7% | 6.6% | ||
| Q1 25 | 1.8% | 6.2% | ||
| Q4 24 | 1.9% | 7.5% | ||
| Q3 24 | 1.7% | 6.7% | ||
| Q2 24 | 1.7% | 6.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.87× | 12.32× | ||
| Q3 25 | 37.76× | 4.61× | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | 0.61× | ||
| Q4 24 | — | 5.35× | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | 2.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
SW
| Packaging | $3.3B | 43% |
| Other | $3.2B | 43% |
| Paper | $1.1B | 14% |
